DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+12.22%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$187M
AUM Growth
+$187M
(+17%)
Cap. Flow
+$8.68M
Cap. Flow
% of AUM
4.64%
Top 10 Holdings %
Top 10 Hldgs %
48.15%
Holding
92
New
14
Increased
20
Reduced
22
Closed
7
Top Buys
| 1 |
Becton Dickinson
BDX
|
$2.5M |
| 2 |
AbbVie
ABBV
|
$1.82M |
| 3 |
Gilead Sciences
GILD
|
$1.66M |
| 4 |
Alibaba
BABA
|
$1.63M |
| 5 |
Morgan Stanley
MS
|
$1.54M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$1.49M |
| 2 |
iShares Biotechnology ETF
IBB
|
$1.35M |
| 3 |
Cisco
CSCO
|
$1.18M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
$1.13M |
| 5 |
Verizon
VZ
|
$1.13M |
Sector Composition
| 1 | Healthcare | 41.77% |
| 2 | Technology | 17.2% |
| 3 | Communication Services | 9.79% |
| 4 | Financials | 6.09% |
| 5 | Consumer Discretionary | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$96B
| $2.48M | 1.02% |
40,000
-1,500
| -4% | -$93K |
|
27
Intel
INTC
$107B
| $2.44M | 1.01% |
49,000
+26,500
| +118% | +$1.32M |
|
|
ALXN
28
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.34M | 0.97% |
15,000
+2,000
| +15% | +$313K |
|
|
SGEN
29
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.33M | 0.96% |
13,300
+300
| +2% | +$52.5K |
|
30
General Motors
GM
$55.8B
| $2.29M | 0.94% |
55,000
+30,000
| +120% | +$1.25M |
|
|
XLNX
31
DELISTED
Xilinx Inc
XLNX
| $1.67M | 0.69% |
11,750
-8,000
| -41% | -$1.13M |
|
|
32
Gilead Sciences
GILD
$140B
| $1.66M | 0.68% |
+28,500
| New | +$1.66M |
|
|
33
Alibaba
BABA
$322B
| $1.63M | 0.67% |
+7,000
| New | +$1.63M |
|
|
34
Morgan Stanley
MS
$240B
| $1.54M | 0.64% |
+22,500
| New | +$1.54M |
|
|
STEW
35
SRH Total Return Fund
STEW
$1.79B
| $1.3M | 0.54% |
116,593
+3,800
| +3% | +$42.3K |
|
36
Lowe's Companies
LOW
$145B
| $1.2M | 0.5% |
7,500
| – | – |
|
37
FibroGen
FGEN
$47.8M
| $1.15M | 0.47% |
31,000
+7,000
| +29% | +$260K |
|
38
LENSAR
LNSR
$147M
| $1.14M | 0.47% |
+157,250
| New | +$1.14M |
|
39
Nokia
NOK
$23.1B
| $1.13M | 0.47% |
290,000
+30,000
| +12% | +$117K |
|
40
Eli Lilly
LLY
$657B
| $1.01M | 0.42% |
+6,000
| New | +$1.01M |
|
41
Esperion Therapeutics
ESPR
$448M
| $1M | 0.41% |
38,500
-18,000
| -32% | -$468K |
|
42
Aptiv
APTV
$17.3B
| $977K | 0.4% |
7,500
| – | – |
|
43
Teradata
TDC
$1.98B
| $955K | 0.39% |
+42,500
| New | +$955K |
|
|
AMRN
44
Amarin Corp
AMRN
$311M
| $929K | 0.38% |
190,000
-59,750
| -24% | -$292K |
|
45
Target
TGT
$43.6B
| $883K | 0.36% |
5,000
| – | – |
|
46
Apple
AAPL
$3.45T
| $862K | 0.36% |
6,500
-1,500
| -19% | -$199K |
|
47
iShares Silver Trust
SLV
$19.6B
| $860K | 0.35% |
35,000
-15,000
| -30% | -$369K |
|
48
Virgin Galactic
SPCE
$179M
| $831K | 0.34% |
+35,000
| New | +$831K |
|
49
Johnson & Johnson
JNJ
$427B
| $787K | 0.32% |
+5,000
| New | +$787K |
|
|
AYX
50
DELISTED
Alteryx, Inc.
AYX
| $731K | 0.3% |
+6,000
| New | +$731K |
|